Recent trends in glaucoma surgery: a nationwide database study in Japan, 2011–2019

Fujita, Asahi; Hashimoto, Yukihiko; Matsui, Hiroki; Yasunaga, Hideo; Aihara, Makoto

doi:10.1007/s10384-021-00898-6

Cited by 17 publications

(18 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…During a 24-month follow-up, the mean IOP dropped from 21.4 ± 7.4 to 12.1 ± 2.4 mm Hg (P < 0.05), and the mean number of topical IOP-lowering medications decreased from 2.5 to 0.8 (P < 0.05). The success rate was 78%, which was defined as an IOP reduction ≥ 20% from baseline with IOP maintained between 6 and 21 mm Hg Conjunctival hyperemia (15) Keratic precipitates (15) from month 3 of follow-up, without further glaucoma surgery.…”

Section: Efficacy and Safety Of Migs In Pacgmentioning

confidence: 99%

“…Minimally invasive glaucoma surgery (MIGS) has become one of the mainstream surgical options to treat primary open-angle glaucoma (POAG). In the past few years, an increasing trend of MIGS has been observed in India,13 Germany,14 Japan,15 and the United States 16. In the United States, the number of annual MIGS procedures almost doubled from 31,059 in 2013 to 60,420 in 2018 16.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Minimally Invasive Glaucoma Surgery in Primary Angle-Closure Glaucoma

Song

Zhang

et al. 2022

Asia-Pacific Journal of Ophthalmology

View full text Add to dashboard Cite

Primary angle-closure glaucoma (PACG) is responsible for half of the glaucoma-related blindness worldwide. Cataract surgery with or without trabeculectomy has been considered to be the first-line treatment in eyes with medically uncontrolled PACG. While minimally invasive glaucoma surgery has become an important surgical approach for primary open-angle glaucoma, its indications and benefits in PACG are less clear. This review summarizes the efficacy and safety profile of minimally invasive glaucoma surgery in PACG to unfold new insights into the surgical management of PACG.

show abstract

Section: Efficacy and Safety Of Migs In Pacgmentioning

confidence: 99%

mentioning

confidence: 99%

Minimally Invasive Glaucoma Surgery in Primary Angle-Closure Glaucoma

Song

Zhang

et al. 2022

Asia-Pacific Journal of Ophthalmology

View full text Add to dashboard Cite

show abstract

“…Another one develops new MIGS devices to provide an alternative pathway through which aqueous humor can effectively exit the anterior chamber, reducing IOP (40)(41)(42). MIGS is widely becoming the front-line glaucoma surgery with respect to various advantages (43)(44)(45)(46)(47)(48).…”

Section: Glaucomamentioning

confidence: 99%

Grand Challenges and Opportunities in Surgical Ophthalmology: Together for a Shared Future

et al. 2022

View full text Add to dashboard Cite

“…[2] The number of glaucoma surgeries has been reported to have increased by more than 200% from 2011 to 2019 in Japan. [3] This increase has been attributed to an increase in the number of advanced stage patients in the Japanese aging society and reductions in invasiveness due to advancements in surgical techniques. Since the number of patients with glaucoma is expected to increase worldwide by 74% in 2040 compared with that in 2013, [4] the number of incisional glaucoma surgeries and laser therapies will continue to increase in the near future.…”

Section: Introductionmentioning

confidence: 99%

One-year costs of incisional glaucoma surgery and laser therapy

et al. 2023

Self Cite

View full text Add to dashboard Cite

Background: This study aimed to calculate one-year total costs of incisional glaucoma surgery and laser therapy in a real-world clinical setting.Methods: We conducted a retrospective cohort study from July 2010 to March 2021 using the Diagnosis Procedure Combination database. We included patients hospitalized for incisional glaucoma surgery (trabeculectomy, trabeculotomy, tube shunt surgery, Ex-PRESS surgery, or iStent implantation) or laser therapy (laser peripheral iridotomy, surgical iridectomy, laser trabeculoplasty, cyclocryotherapy, or cyclophotocoagulation).The outcomes were total costs, including costs of hospitalization, re-admissions, antiglaucoma drugs, ophthalmic examinations, and outpatient visits for incisional glaucoma surgery and laser therapy within one year.Results: We identified 49,202 eligible hospitalizations. The one-year median total cost was 707,497 yen [interquartile range: 546,887-944,664 yen]. The median total cost was the highest in patients undergoing tube shunt surgery, followed by Ex-PRESS surgery, iStent implantation, and trabeculectomy. The number and cost of postoperative outpatient visits and length of hospital stay were higher in patients who underwent trabeculectomy and Ex-PRESS surgery than in those after tube shunt surgery. The total 4 costs of laser therapies were lower than those of incisional glaucoma surgeries. The total cost was the highest in the 0-19 age group (856,398 [649,419-1,258,844] yen).Conclusions: Tube shunt surgery was the costliest in terms of total one-year costs.Trabeculectomy and Ex-PRESS surgery were associated with long hospital stays and incurred high postoperative costs. The costs of laser therapies were relatively low.However, cost-effectiveness of laser therapies compared with incisional surgeries needs to be analyzed in future research.

show abstract

Recent trends in glaucoma surgery: a nationwide database study in Japan, 2011–2019

Cited by 17 publications

References 38 publications

Minimally Invasive Glaucoma Surgery in Primary Angle-Closure Glaucoma

Minimally Invasive Glaucoma Surgery in Primary Angle-Closure Glaucoma

Grand Challenges and Opportunities in Surgical Ophthalmology: Together for a Shared Future

One-year costs of incisional glaucoma surgery and laser therapy

Contact Info

Product

Resources

About